Theralase Technologies uses Virginia Tech research to successfully destroy breast cancer cells

Files
TR Number
Date
2010-01-25
Journal Title
Journal ISSN
Volume Title
Publisher
Virginia Tech. University Relations
Abstract

Compounds developed by researchers at Virginia Tech, have proven effective in destroying breast cancer cells when used with lasers developed by Theralase Technologies (TSX-V: TLT) out of Toronto. Theralase, an international manufacturer of laser medical devices, reports that its patented photodynamic compounds (PDCs) developed at the university, when used with its lasers, destroy breast cancer cells in pre-clinical trials.

Description
Keywords
College of Science
Citation